LEARN ABOUT HOW STOCK BASHERS WORK: how they are paid: (this was written by a basher) I know the following from a "friend" who needed extra money. I never answer a basher directly because I then become a basher's little money machine. IGNORE THEM FOLKS...how bashers are paid: When you REPLY to bashers you give them an opportunity to earn 5-7 bucks. The service agreement they enter into with their employer states their messages will be monitored for content, profanity, lies, etc. but Money Manager's and the like don't have the time to check all their bashers messages. Only occasional spot checks are done. Those who manage the basher will generally read the headlines to see if a basher is replying to other posters by name. That tells them the basher isn't just "posting blindly" or repeating the same message over and over (rubber soul) since they won't pay for those. A basher will attempt to milk three to five replies per post at one to two dollars each. This way the basher spreads negative influence to as many stockholders as possible. A basher will create this discussion thread because it takes less time reading more messages than is necessary. This ultimately allows the basher more time to post and make money. In general, NEVER ENGAGE A BASHER. Make them read all the posts and think up ways to enter the discussion.
NEVER ENGAGE A STOCK BASHER; if you do so then YOU BECOME THE BASHER'S AID!
Read the news, do your own homework and make your own decisions. Get real time quotes and follow the stock for a couple of weeks. Due Diligence is key here. Know that there will be a time when the stock runs up which will be followed by the Bashers and those that missed the boat. The bashers will trash the stock by saying such things as "it's a Pump and Dump" and "the company is lying" and deceiving. There goal is to scare off newbies and potential new investors by "shaking" you out of your shares. Take the time to confirm your Due Diligence, ,trust your own judgment
Sentiment: Strong Buy
05/22/2015 TRx: 249 NRx: 199
In comparison, last week's were:
05/15/2015 TRx: 214 NRx: 165
Solid week! Wonder how Memorial Day will impact this week's numbers that come out next Friday.
You make an interesting proposal. Perhaps I should start a virtual corporation without any assets, sales, or employees. Since the stock would have a book value of zero, which is considerably greater than the negative book of RSHCQ, I could probably sell it for over $1 per share.
Recognia is part of my trading account tools and looks for technical set ups...this was one of the featured trades today...I am hopeful!
Sentiment: Strong Buy
I sold yesterday in the mid 5's for an incredible gain and hoping it continues back down so I can pick some shares back up on the cheap.
Take the time to read the recent news. Rumor is the company will likely get bought out within the next 60 days.
Check out the companies OHGI is involved with.......WOW
Your welcome :-)
Who selects the AdCom, Nerd? Any danger of it being a pick-a-pal system? And any chance that the bleedin' obvious Aussie signs on? Thanks, mate.
illary and her husband, who incidentally has abused more women than we can count,
You offer up a single example from 25 years ago? Surely you can do better than this
Nothing they did accomplished a thing more than convincing folks to break out the credit cards and go back into debt. America is now a debtor nation that runs on credit. Next collapse is coming not if but when. How long can the FED keep interest rates a zero. Just like printing money.
Propanc Health Group Corp (OTCMKTS:PPCH) has acquired the services of Maxim Group as strategic advisor to the bio-medical company. Propanc works on the development of proprietary treatments for cancer patients. Currently, the company is studying the effects of PRP on cancer stem cells. The study is being carried out at the University of Jaen, in Spain. At the moment the company is just trying to find out what happens to the stem cells targeted by PRPs. Whether it would lead to another novel drug from PPCH, is yet to be known.
Maxim Group has been given the responsibilities to provide strategic planning and investment banking services to PPCH. Propanc plans to increase its shareholder value, which is in sub-penny land, through investment banking. This also includes efforts by the two companies to get PPCH listed on a national exchange. Maxim believes that Propanc has significant potential. It highlights that Propanc has a highly qualified management team, a large market for its products and a strong portfolio. All these factors combined, reflect on the true potential of PPCH, which Maxim would like to make the most of.
The company’s study targeting cancer stem cells is targeted at finding out the after effects of treating the cells with PRP. The study would be the latest in a series of studies by Propanc on tumor cells. One of the previously published studies by the company had revealed that PRP induces differentiation among tumor cells, but does that happen to CSCs as well.
CSCs are known to help in the formation of tumors and treatment resistance. Unfortunately, chemotherapy or radiotherapy is unable to rid the body of these cells, since they stay in a latent state. The outcome is a relapse of the deadly disease. However, it remains to be seen whether the study would lead to a new drug for the PPCH. If the findings of the study are positive, it can even lead to the development of a vaccine.
Propanc Health Group Corp (OTCMKTS:PPCH) closed at $0.0765, without r
Sentiment: Strong Buy
If the list is long furnish some more examples. Once again your opinion isn't needed, just facts, if you have them
Then sell fast!
Oh wait, you're not long Nokia because it's all hype?
Then why are you bashing?
Your on ignore from hereon in.
I suggest everyone else do the same to you and the likes of everyone like you.
we know now that even 35% doctors are not aware about Afrezza existence on market. Each third PCP/endo never hear word AFREZZA. It means that other 65% are aware but don't know about advantages in compare with injectable meal-time insulins.
So, it's absolutely useless to monitor script numbers now. 95% diabetics don't know what is AFREZZA. But when they know at least 20-30% of them will ask their doctors to prescribe Afrezza and will get it immediately.
Sentiment: Strong Buy
Agree..... Stay long. Adding today. NBY went down but recovered. Accumulation going on.